MedPharm

MedPharm

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MedPharm is a long-established, privately-held CDMO that has carved out a strong niche in the topical and transdermal drug delivery sector. The company offers a fully integrated suite of services, including formulation development, analytical and bioanalytical testing, specialized in-vitro permeation models, and GMP clinical and commercial manufacturing. With deep scientific expertise and a focus on regulatory compliance, MedPharm serves pharmaceutical clients globally, supporting generics, OTC, and prescription products from concept to market. Its business model is entirely service-based, generating revenue from client projects across the development lifecycle.

Dermatology

Technology Platform

Specialized in-vitro testing platforms for topical/transdermal products, including High Throughput Skin Permeation Testing, In Vitro Permeation Testing (IVPT), In Vitro Release Testing (IVRT), Reconstructed Human Epithelium (RHE) models, and Nail Permeation testing.

Opportunities

The growing global market for topical and transdermal drug delivery, driven by patient preference and therapeutic advantages, presents a significant expansion opportunity.
Increased outsourcing by pharmaceutical companies, especially for complex formulation expertise, provides a steady stream of potential clients.

Risk Factors

Revenue is contingent on client project success and subject to pipeline volatility.
Intense competition from larger CDMOs and regulatory risks associated with GMP manufacturing and quality compliance pose significant threats.

Competitive Landscape

MedPharm competes in a niche segment against other specialized dermatology CDMOs and the topical/transdermal divisions of large, global CDMOs. Its competitive advantage is its deep, focused expertise and end-to-end integrated service model for a specific dosage form.